FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387661617> ?p ?o ?g. }

• W4387661617 endingPage "9476" @default.
• W4387661617 startingPage "9470" @default.
• W4387661617 abstract "Since December 2019, Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused a threatening situation worldwide. The new variant of SARS-CoV-2, BA.2.86, also known as Pirola, is an Omicron subvariant that causes great concern because it has been found to contain a large number of mutations. This study aims to investigate and identify the biological and clinical characteristics of this threatening new variant of SARS-CoV-2, which is BA.2.86.This observational study was performed in the Department of Physiology, College of Medicine, King Saud University, Riyadh, Saudi Arabia. The literature was searched using the key terms including SARS-CoV-2, Omicron, BA.2.86, Pirola, epidemiology, clinical characteristics. The data on Omicron BA.2.86 were obtained from the World Health Organization (WHO), Centers for Disease Control and Prevention (CDC), the Global Initiative on Sharing All Influenza Data (GSIAD), PubMed, Web of Science, regional ministries, research institutes, and international print media. Initially, 26 documents were identified and 10 documents were included for the data analysis. The information on the prevalence and the biological characteristics of the new variant of SARS-CoV-2, Omicron BA.2.86, was recorded and synthesized for analysis.The Omicron BA.2.86 has been identified in 23 countries with 264 confirmed cases as of September 28, 2023. The number and distribution of these cases encompass the United Kingdom 66 (25.0%), USA 34 (12.87%), Denmark 31 (11.74%), Sweden 25 (9.46%), South Africa 20 (7.57%), Spain 20 (7.57%), France 15 (5.68%), Portugal 7 (2.65%), Japan 6 (2.27%), Canada 5 (1.89%), Thailand 5 (1.89%), Israel 5 (1.89%), Greece 5 (1.89%), Germany 3 (1.13%), Belgium 3 (1.13%), Luxembourg 3 (1.13%), Netherlands 3 (1.13%), South Korea 3 (1.13%). However, one case in each country has been reported in Australia, Italy, Iceland, Switzerland, and China. The disease has been reported more frequently in females (71.0%) than males (29.0%). To date, no deaths have been reported. The novel variant has spread more swiftly than other variants of SARS-CoV-2 and has crossed many international borders.The new Omicron variant BA.2.86 has affected 264 people in 23 countries. The disease is more common in females than males and mainly affects old age people (over 60 years of age). However, no deaths have been reported. The variant is spreading swiftly and transmitted more rapidly. The clinical manifestations in patients with Omicron BA.2.86 variant are not well documented and may be similar to earlier strains of COVID-19 by presenting with mild infectious symptoms, including headache, body ache, cough, fever, generalized myalgia, and severe fatigue. The global health authorities must take preventive measures to stop the outbreak of this emerging variant across the globe to minimize the disease burden." @default.
• W4387661617 created "2023-10-17" @default.
• W4387661617 creator A5029714576 @default.
• W4387661617 creator A5053461351 @default.
• W4387661617 creator A5093068218 @default.
• W4387661617 date "2023-10-01" @default.
• W4387661617 modified "2023-10-17" @default.
• W4387661617 title "Omicron new variant BA.2.86 (Pirola): Epidemiological, biological, and clinical characteristics - a global data-based analysis." @default.
• W4387661617 doi "https://doi.org/10.26355/eurrev_202310_33975" @default.
• W4387661617 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37843359" @default.
• W4387661617 hasPublicationYear "2023" @default.
• W4387661617 type Work @default.
• W4387661617 citedByCount "0" @default.
• W4387661617 crossrefType "journal-article" @default.
• W4387661617 hasAuthorship W4387661617A5029714576 @default.
• W4387661617 hasAuthorship W4387661617A5053461351 @default.
• W4387661617 hasAuthorship W4387661617A5093068218 @default.
• W4387661617 hasConcept C107130276 @default.
• W4387661617 hasConcept C126322002 @default.
• W4387661617 hasConcept C23131810 @default.
• W4387661617 hasConcept C2779134260 @default.
• W4387661617 hasConcept C3007834351 @default.
• W4387661617 hasConcept C3008058167 @default.
• W4387661617 hasConcept C524204448 @default.
• W4387661617 hasConcept C71924100 @default.
• W4387661617 hasConceptScore W4387661617C107130276 @default.
• W4387661617 hasConceptScore W4387661617C126322002 @default.
• W4387661617 hasConceptScore W4387661617C23131810 @default.
• W4387661617 hasConceptScore W4387661617C2779134260 @default.
• W4387661617 hasConceptScore W4387661617C3007834351 @default.
• W4387661617 hasConceptScore W4387661617C3008058167 @default.
• W4387661617 hasConceptScore W4387661617C524204448 @default.
• W4387661617 hasConceptScore W4387661617C71924100 @default.
• W4387661617 hasIssue "19" @default.
• W4387661617 hasLocation W43876616171 @default.
• W4387661617 hasOpenAccess W4387661617 @default.
• W4387661617 hasPrimaryLocation W43876616171 @default.
• W4387661617 hasRelatedWork W3084498529 @default.
• W4387661617 hasRelatedWork W3176864053 @default.
• W4387661617 hasRelatedWork W3198183218 @default.
• W4387661617 hasRelatedWork W4205317059 @default.
• W4387661617 hasRelatedWork W4205810683 @default.
• W4387661617 hasRelatedWork W4206548596 @default.
• W4387661617 hasRelatedWork W4206651655 @default.
• W4387661617 hasRelatedWork W4206669628 @default.
• W4387661617 hasRelatedWork W4224279380 @default.
• W4387661617 hasRelatedWork W4292098121 @default.
• W4387661617 hasVolume "27" @default.
• W4387661617 isParatext "false" @default.
• W4387661617 isRetracted "false" @default.
• W4387661617 workType "article" @default.